Our results identified factors such as age, PSA level, surgery, and radiotherapy as key risk factors for prognosis, with tumor metastasis (M stage) emerging as the most significant predictor of survival at 1 and 3 years, and PSA level as the strongest predictor at 5 years. Here, KLK3 is linked to neoplasm.